<DOC>
	<DOCNO>NCT00192543</DOCNO>
	<brief_summary>Cardiovascular disease main cause death patient dialysis end stage renal disease . Omega-3 fatty acid antioxidant show protective general population . A diet fish fruit , provide fatty acid antioxidant tried dialysis patient assess effect cardiovascular disease high risk group .</brief_summary>
	<brief_title>The Fish Fruit Study : Trial Fish Fruit Improve Survival Aboriginal People With End Stage Renal Disease</brief_title>
	<detailed_description>End stage renal disease ( ESRD ) devastate disease affect Aboriginal Australians disproportionately : The average survival time Aboriginal people Northern Territory 3.6 year onset kidney failure , compare 12.3 year non-Aboriginal people . There dramatic rise incidence kidney failure past 20 year , prevalence double every 4-5 year many NT community remote part Australia . Mortality patient ESRD approximately 5 10 fold general population , heart disease accounting approximately half death . The aim study determine whether dietary intervention fish fruit three time week decrease cardiovascular all-cause mortality patient haemodialysis Darwin Alice Springs . There strong scientific rationale simple dietary intervention . Fish rich source omega-3 fatty acid , believe reduce risk heart attack . Fruit good source anti oxidant chemical may amplify beneficial effect fish . Participants randomize either control intervention group accord regular day dialysis . Nutritional cardiovascular status measure commencement study interval 3 , 6 12 month . Strategies incorporate project design ensure understanding , informed consent participation Aboriginal people number domain : participant , family , urban remote community , service provider . If successful intervention result change clinical management renal patient worldwide .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>All patient hemodialysis Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>dialysis</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>antioxidant</keyword>
	<keyword>cardiovascular marker</keyword>
	<keyword>Mortality</keyword>
	<keyword>End-stage renal disease</keyword>
</DOC>